A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
PHASE2
The primary objective is to compare the safety and efficacy of multiple dos...
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
PHASE3
The objective of this study is to evaluate the efficacy and safety of upada...
Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis
PHASE3
Pediatric atopic dermatitis (AD), also known as childhood eczema, is a skin...
A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE3
The objective of this study is to assess the safety of upadacitinib combine...
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE3
Atopic dermatitis (AD) is a skin condition that may cause a rash and itchin...
A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)
PHASE3
The study objectives of Period 1 of this study were to compare the efficacy...
Status
Completed
Location
Ceti - Centro de Estudos Em Terapias Inovadoras Ltda /Id# 152964